Clinical Trial Detail

NCT ID NCT01757327
Title LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements yes
Sponsors Washington University School of Medicine
Indications

Her2-receptor negative breast cancer

Therapies

Sonidegib

Age Groups: adult

Additional content available in CKB BOOST